Physician PracticeResearch Use Only

ADMAX

Longer-acting Semax analog (Adamax) with extended duration of action. Used as an alternative to Semax when once-daily dosing is preferred. Very limited independent evidence beyond Semax mechanism extrapolation.

CognitiveNootropicSemax AnalogInjectableOnce Daily
QUICK FACTS
ALSO KNOWN ASAdamax — longer-acting Semax derivative
CLASSExtended ACTH analog / Semax derivative
ADVANTAGEOnce-daily dosing vs Semax 2–3x/day
EVIDENCE STATUSVery limited independent evidence
WADA STATUSNot prohibited
Overview

ADMAX (Adamax) is a longer-acting variant of Semax, modified to extend its duration of action. The primary pharmacokinetic advantage is extended half-life allowing once-daily dosing compared to the 2–3x daily dosing of Semax.

The mechanism is assumed to be similar to Semax — BDNF upregulation, neuroprotective effects — based on structural relationship. However, independent clinical or preclinical data for ADMAX specifically is extremely limited.

In physician practice, Joseph describes ADMAX as an alternative to Semax rather than a routine companion. It may be preferred when compliance with multiple daily doses is a concern, or when a smoother effect profile is desired.

Research Areas
Cognitive enhancement researchNeuroprotection researchBDNF pathway researchOnce-daily nootropic researchSemax pharmacology variantsNootropic peptide research
Available Evidence3 categories
Very Limited HumanNo independent human clinical trial data. Physician practice extrapolation from Semax data and structural relationship.
MinimalLimited independent in vitro data. Mechanism assumed similar to Semax based on structure.
Highly UncertainMost limited evidence base in the cognitive category. Approach with appropriate epistemic humility.
Documented Research Benefits6 documented
Cognitive enhancement (proposed)
physician practice extrapolation
BDNF upregulation (proposed)
Semax extrapolation
Neuroprotection (proposed)
Semax extrapolation
Once-daily convenience
pharmacokinetic advantage
Longer duration of action
pharmacokinetic
Semax alternative dosing
physician practice
Research Pairings3 common
Selank
Standard cognitive pairing — same role as Semax + Selank with ADMAX’s once-daily advantage.
View Selank →
Semax
Generally an alternative — not combined. Choose Semax (2–3x/day) or ADMAX (once daily).
View Semax →
P21
BDNF addition in comprehensive cognitive protocols.
View P21 →

What are you researching?

Tell us your focus area and we’ll send a personalized research guide.

Safety & Regulatory Status

ADMAX has essentially no independent safety data from controlled human studies. The risk profile is unknown beyond inference from Semax pharmacology. Research use only. Not WADA-prohibited. Approach with significant caution given very limited data. All information for educational reference only.

Get the Research Guide

Research summaries, evidence tiers, and COA-verified sourcing. Published by Forge Scientific. No spam.